Genflow Biosciences plc (LON:GENF – Get Free Report) traded down 28.6% on Wednesday . The company traded as low as GBX 1.26 and last traded at GBX 1.50. 8,528,073 shares changed hands during mid-day trading, an increase of 234% from the average session volume of 2,552,744 shares. The stock had previously closed at GBX 2.10.
Genflow Biosciences Stock Performance
The company has a market capitalization of £7.65 million, a price-to-earnings ratio of -3.09 and a beta of 2.37. The firm has a 50-day simple moving average of GBX 1.90 and a two-hundred day simple moving average of GBX 1.56.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
